United States· US:85006-2908_42277606-719f-1fd3-e063-6394a90ad9d6
AHZANTIVE
A medicinal product containing aflibercept-mrbb, registered in United States by Valorum Biologics, LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- AFLIBERCEPT-MRBB
- Manufacturer
- Valorum Biologics, LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1185006-2908-1
- ndc118500629081.05 mL in 1 VIAL, SINGLE-DOSE (85006-2908-1)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Aflibercept-mrbb in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAfivegSTADA Arzneimittel AG
- CzechiaAFIVEGSTADA Arzneimittel AG, Bad Vilbel
- BelgiumAfiveg 40 mg/mlStada Arzneimittel
- SwedenAfiveg 40 mg/ml Injektionsvätska, lösningSTADA Arzneimittel AG
- IcelandAfivegSTADA Arzneimittel AG
- SpainAFQLIR 40 MG/ML SOLUCION INYECTABLE EN JERINGA PRECARGADASandoz Gmbh
- NetherlandsAfiveg 40 mg/ml oplossing voor injectieStada Arzneimittel AG
- IrelandAfiveg 40 mg/mL solution for injectionStada Arzneimittel AG
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Vgenfli
- Iceland · Afiveg, Afqlir
- Liechtenstein · Afiveg, Afqlir
- Norway · Afiveg, Afqlir
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b239e57c-2ca5-4d84-b940-8a46086579c4 GET /v1/drugs/b239e57c-2ca5-4d84-b940-8a46086579c4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVITREAL",
"source": "ndc",
"strength": "40",
"substance": "AFLIBERCEPT-MRBB",
"productndc": "85006-2908",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "BLA761378",
"marketing_category": "BLA"
}See everything about aflibercept-mrbb.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.